TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose

Title
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients – A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose
Authors
Keywords
Lipoprotein apheresis, Iron supplementation, Iron deficiency, Iron deficiency anemia, Ferric gluconate (FG), Ferric carboxymaltose (FCM)
Journal
ATHEROSCLEROSIS SUPPLEMENTS
Volume 18, Issue -, Pages 199-208
Publisher
Elsevier BV
Online
2015-05-01
DOI
10.1016/j.atherosclerosissup.2015.02.030

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started